Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-25

Clinical Trial Update: HEALEY ALS Platform Trial - Regimen A Zilucoplan [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 results for Zilucoplan within the HEALEY ALS Platform Trial Regimen A in amyotrophic lateral sclerosis have been completed with results posted in 2023…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zilucoplan (zilucoplan)

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-25